Showing results (1721-1730 of 1,820) with videos related to

Sort By:
Pageof 182
Pulmonary Circulation|May 4, 2022
Evaluation of the effect of nitric oxide inhalation in the patients with chronic thromboembolic pulmonary hypertension or pulmonary disease during balloon pulmonary angioplastyShota Saito, Nobutaka Ikeda, Raisuke Iijima, et al.
Pulmonary Circulation|May 8, 2023
Insulin-like growth factor binding Protein-4: A novel indicator of pulmonary arterial hypertension severity and survivalGuillermo Torres, Jun Yang, Megan Griffiths, et al.
Pulmonary Circulation|May 9, 2023
Impact of the COVID-19 pandemic on chronic disease management and patient reported outcomes in patients with pulmonary hypertension: The Pulmonary Hypertension Association RegistryMegan Mayer, David B Badesch, Kelly H Nielsen, et al.
Pulmonary Circulation|April 3, 2023
A rare case of Rosai-Dorfman disease presenting as a pulmonary artery mass in a 33-year-old female with hypoxiaVeena Dronamraju, Kaitlyn McSurdy, Ryan Graham, et al.
Pulmonary Circulation|April 6, 2023
Prognosis in Hispanic patient population with pulmonary arterial hypertension: An application of common risk stratification modelsKahtan Fadah, Jose B Cruz Rodriguez, Haider Alkhateeb, et al.
Pulmonary Circulation|April 19, 2021
Impact of the new definition for pulmonary hypertension in patients with lung disease: an analysis of the United Network for Organ Sharing databaseSteven D Nathan, Scott D Barnett, Christopher S King, et al.
Pulmonary Circulation|April 19, 2021
Outcomes of pulmonary vasodilator use in Veterans with pulmonary hypertension associated with left heart disease and lung diseaseKari R Gillmeyer, Donald R Miller, Mark E Glickman, et al.
Pulmonary Circulation|April 15, 2021
Circular RNA-HIPK3 regulates human pulmonary artery endothelial cells function and vessel growth by regulating microRNA-328-3p/STAT3 axisLiuqing Hong, Xiaoying Ma, Jiyuan Liu, et al.
Pulmonary Circulation|April 15, 2021
Corrigendum for Effect of riociguat on pulmonary arterial compliance in the PATENT and CHEST studies
Pulmonary Circulation|August 18, 2025
Predicting Response to Switching From Phosphodiesterase Type 5 Inhibitor to Riociguat in Patients With Pulmonary Arterial Hypertension: Biomarker and Responder Analysis of the RESPITE and REPLACE StudiesJames R Klinger, Hikmet Al-Hiti, Sung-A Chang, et al.
Pageof 182